School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
Department of Engineering Design and Mathematics, Faculty of Environment and Technology, University of West of England, Bristol, UK.
Exp Physiol. 2022 Apr;107(4):350-358. doi: 10.1113/EP090238. Epub 2022 Mar 4.
What is the central question of this study? Is the frequency dependence of co-transmitter release from postganglionic nerve fibres different for each transmitter? What is the main finding and its importance? Release of co-transmitters from the parasympathetic supply to detrusor smooth muscle can be independently regulated. This offers a targeted drug model to reduce selectively the release of transmitter associated with human pathologies (ATP) and may also be applicable to other smooth muscle-based disorders of visceral tissues.
Nerve-mediated contractions of detrusor smooth muscle are mediated by acetylcholine (ACh) and ATP release in most animals. However, with the normal human bladder, only ACh is a functional transmitter, but in benign pathologies such as overactive bladder (OAB), ATP re-emerges as a secondary transmitter. The selective regulation of ATP release offers a therapeutic approach to manage OAB, in contrast to current primary strategies that target ACh actions. However, the release characteristics of nerve-mediated ACh and ATP are poorly defined and this study aimed to measure the frequency dependence of ACh and ATP release and determine if selective regulation of ATP or ACh was possible. Experiments were carried out in vitro with mouse detrusor with nerve-mediated ATP and ACh release measured simultaneously with tension recording. ATP was released in two frequency-dependent components, both at lower frequencies (mid-range 0.4 and 5.5 Hz stimulation) compared to a single compartment release of ACh at 14 Hz. Intervention with the phosphodiesterase type-5 inhibitor sildenafil attenuated ATP release, equally from both components, but had no effect on ACh release. These data demonstrate that nerve-mediated ACh and ATP release characteristics are distinct and may be separately manipulated. This offers a potential targeted drug model to manage benign lower urinary tract conditions such as OAB.
这项研究的核心问题是什么?副交感神经节后纤维共递质释放的频率依赖性是否因递质而异?主要发现及其重要性是什么?副交感神经对逼尿肌平滑肌的递质释放可以独立调节。这为减少与人类病理相关的递质(ATP)释放提供了一个靶向药物模型,也可能适用于其他内脏组织的平滑肌相关疾病。
在大多数动物中,逼尿肌平滑肌的神经介导收缩是由乙酰胆碱 (ACh) 和 ATP 释放介导的。然而,对于正常的人类膀胱,只有 ACh 是功能性递质,但在良性病理如膀胱过度活动症 (OAB) 中,ATP 重新成为次要递质。ATP 释放的选择性调节为管理 OAB 提供了一种治疗方法,与当前针对 ACh 作用的主要策略形成对比。然而,神经介导的 ACh 和 ATP 释放的释放特征尚未明确,本研究旨在测量 ACh 和 ATP 释放的频率依赖性,并确定是否可以选择性调节 ATP 或 ACh。实验在体外进行,用鼠标逼尿肌进行,同时进行张力记录以测量神经介导的 ATP 和 ACh 释放。ATP 以两种频率依赖性成分释放,均在较低频率(中范围 0.4 和 5.5 Hz 刺激)下释放,而 ACh 则在 14 Hz 下以单个隔室释放。磷酸二酯酶 5 型抑制剂西地那非的干预减弱了 ATP 释放,两种成分均减弱,但对 ACh 释放没有影响。这些数据表明,神经介导的 ACh 和 ATP 释放特征是不同的,可能分别进行操作。这为管理良性下尿路疾病(如 OAB)提供了一个潜在的靶向药物模型。